Which antibodies can be detected in a patient suffering from polymyositis?
**Core Concept:** Polymyositis is a group of autoimmune diseases that primarily affect skeletal muscles, leading to inflammation and muscle weakness. Antibodies are proteins produced by the immune system that can be used to diagnose autoimmune diseases. In the context of polymyositis, specific antibodies can be detected in the patient's blood.
**Why the Correct Answer is Right:** In polymyositis, the immune system mistakenly attacks the person's own muscle cells, causing inflammation and muscle damage. Antibodies, which are produced in response to foreign antigens, are detected in the blood of patients with autoimmune diseases like polymyositis. In the case of polymyositis, the following antibodies can be detected:
1. Anti-Mi-2 antibodies: These are specific to dermatomyositis, a subtype of polymyositis characterized by skin involvement.
2. Anti-Jo-1 antibodies: They are associated with a specific subtype of polymyositis called dermatomyositis.
3. Anti-histone antibodies: These are found in some cases of dermatomyositis and are also associated with systemic sclerosis.
4. Anti-SRP antibodies: They are detected in some cases of dermatomyositis and are also associated with renal involvement.
**Why Each Wrong Option is Incorrect:**
A. Anti-nuclear antibodies (ANA) are commonly detected in systemic autoimmune diseases like systemic lupus erythematosus (SLE). These antibodies are not specific to polymyositis and are not relevant to the question.
B. Anti-Ro/SSA antibodies are detected in patients with Sjögren's syndrome and systemic lupus erythematosus (SLE), not in polymyositis.
C. Anti-La/SSB antibodies are detected in patients with Sjögren's syndrome and systemic lupus erythematosus (SLE), not in polymyositis.
D. Anti-centromere antibodies are detected in patients with systemic sclerosis, not in polymyositis.
**Clinical Pearl:** A high index of suspicion and knowledge of specific autoantibodies can help differentiate between different autoimmune diseases and guide appropriate diagnosis and management strategies. A negative result for the mentioned antibodies does not exclude polymyositis but helps rule out other autoimmune diseases with overlapping clinical features.